Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-02-17 @ 4:41 PM
Study NCT ID:
NCT01754857
Status:
COMPLETED
Last Update Posted:
2023-06-27
First Post:
2012-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
Sponsor:
University of Wisconsin, Madison
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HO11414
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None